This event has ended. Visit the official site or create your own event on Sched.
                                                      THIS EVENT IS OVER NOW

Recordings of the sessions are available NOW by clicking on the session you are interested in.

ISC and its partners organised the 9th edition of the Science Summit around the 78th United Nations General Assembly (UNGA78) on 12-29 September 2023.
The role and contribution of science to attaining the United Nations Sustainable Development Goals (SDGs) will be the central theme of the Summit. The objective is to develop and launch science collaborations to demonstrate global science mechanisms and activities to support the attainment of the UN SDGs, Agenda 2030 and Local2030. The meeting will also prepare input for the United Nations Summit of the Future, which will take place during UNGA79 beginning on 12 September 2024.
Back To Schedule
Thursday, September 14 • 8:25am - 5:00pm
[VIRTUAL] Pandemic Preparedness: defining the UN-level strategy for the Summit of the Future 2024 - with the National Research Foundation, South Africa (140905)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.

CURE, 345 Park Ave South, New York.
Pay attention to the S-O-U-T-H part, otherwise you will be very lost.

Pandemic Preparedness: Defining the UN-level strategy for the Summit of the Future 2024 with the National Research Foundation, South Africa

Agenda (at 04h28EDT, Thursday 14 September 2023)

08h25 Welcome
Declan Kirrane, Chairman, Science Summit at UNGA78
Seema Kumar, CEO, CURE

08h30 PANEL 1 -- Scene Setting
Petra Jantzer, Life Sciences Global Lead, Accenture (Mod)
Marc Carrel-Billiard, Technology Innovation Global Lead, Accenture
Fulufhelo Nelwamondo, CEO, National Research Foundation, South Africa (V)
Johan Aubert, Chief Digital Officer, Research and Innovation L'Oreal
Hillel Lehmann, Vice President, Head of Transformation & Long-term Strategy, Nestlé Health Sciences
Rob Goodwin, Senior Vice President and Chief Scientific Officer, Vaccine Research and Development, Pfizer

10h00 PANEL 2 Global Challenges Response
Kurt Zatloukal, Medical University Graz, Austria (Mod)
Magdalena Skipper, Editor-in-Chief, Nature, UK
Seema Kumar, CURE by Deerfield, USA
Osamu Kunii, Global Health Innovative Technology Fund, Japan (V)

11h00 Keynote: Aunkh Chabalala, National Director of the Indigenous Knowledge-Based Technology Innovation Unit Dept of Science and Innovation, South Africa

11h15 Break

11h30 PANEL 3 100 Days Mission Panel: The Science of Access to Medical Countermeasures for Pandemic Preparedness

Moderator: Lidia Borrell-Damian, Secretary-General, ScienceEurope

As shown during the response to COVID-19, the faster we can develop safe, effective and affordable diagnostics, therapeutics and vaccines (DTVs) for an escalating infectious disease, the more lives we can save.
The goal of the 100 Days Mission is to prepare as much as possible so that within the first 100 days that a pandemic threat is identified, the following interventions can be made available, safe, effective, and affordable:

Accurate and approved rapid point-of-care diagnostic tests
An initial regimen of therapeutics
Vaccines ready to be produced at scale for global deployment

In 2021, G7 and G20 Leaders welcomed the 100 Days Mission, building on the collaborative scientific efforts which led to the development of DTVs for COVID-19. The 1st 100 Days Mission report was authored by scientific, governmental and industry experts drawn from within and beyond the G7. It proposed 25 recommendations to harness scientific innovation and strengthen public and private collaboration that will reduce the time from discovery to deployment of DTVs within 100 days of the next pandemic threat.

Panel Concept: This session will discuss the following:
Background to the 100 Days Mission, its connection to the wider SDG agenda, and its value proposition for a safer world through scientific innovation to condense timelines and equitable access to countermeasures.
The learnings from COVID-19 and the policy solutions that underpin the 100 Days Mission
How upcoming political processes, including UNHLM on PPR and INB/IHR processes, will support this work, and how other opportunities, including a new MCM network and G7 and G20 presidencies, can make the 100 Days Mission a reality

11h30 - 11h35 Welcome: Dr Victor Dzau (President of the National Academy of Medicine and STEG co-chair) and Dr Rick A Bright (Former Director of BARDA, FIND board member)

11h35 - 11h45 Opening Remarks: Introduction to the 100 Days Mission and Science and Technology Expert Group (STEG) by Dr Victor Dzau (President of the National Academy of Medicine and STEG co-chair)

11h45 - 12h10 Panellist Remarks: 5-minute interventions from
Dr Nicole Lurie (US Director, CEPI), Shingai Machingaidze (Ag. Chief Science Officer, Africa CDC),
Dr Rick A Bright (Former Director of BARDA, FIND Board Member)
Dr Ruxandra Draghia-Akli (V) (Global Head, Johnson & Johnson Global Public Health R&D), on the global lessons captured from COVID-19 for pandemic preparedness R&D and the recommendations for ensuring countermeasures can deliver equity and innovation, with sustainable financial and political will.

12h10-12h45 Moderated Q&A between attendees and panellists

12h45-12h55 Closing Remarks: Global political opportunities for implementing the recommendations by Dr Mariângela Simão (Former WHO Assistant Director-General for Drug Access Vaccines and Pharmaceuticals)

12h55-13h00 Goodbyes: Dr Victor Dzau (President of the National Academy of Medicine and STEG co-chair) and Dr Rick A Bright (Former Director of BARDA, FIND Board Member)

13h00 Lunch (by Invitation)

14h00 Keynote: Policy Responses
Irene Norstedt, European Commission, Belgium:

14h45 PANEL 4 -- Harnessing Indigenous knowledge systems to combat diseases of poverty
Magdalena Skipper, Editor-in-Chief, Nature, UK Moderator
Mosoka Fallah, Founder and Chief Executive Officer (CEO), Refuge Place International
Thomas John, Landcent
Michael Makanga, European Developing Countries Clinical Trails Programme
Aunkh Chabalala, National Director of the Indigenous Knowledge-Based Technology Innovation Unit, Dept of Science and Innovation. South Africa
Peter Atadja, Chief Scientific Advisor, Landcent

15h45 PANEL 5 -- Building Communities of Practice for Interpandemic Sciences in Africa – Science for Africa Foundation
Thomas Kariuki, CEO, Science for Africa Foundation, Kenya
Jinal Bhiman Global Immunology and Immune Sequencing for Epidemic Response South Africa (GIISER-SA), NICD
Christian Happi, Redeemers University, Nigeria

16h30 Recommendation for the Summit of the Future and Concluding Panel
Triona McCormack, UCD, Ireland - Moderator:
Alison Derbenwick Miller, Oracle, USA
Carlos Americo Pacheco, FAPESP
Josef Glößl, BOKU, Austria

Pandemic preparedness is vital for protecting public health, maintaining economic stability, ensuring global health security, strengthening healthcare systems, fostering scientific advancements, reducing risks, and engaging communities. By investing in preparedness, we can minimise the impact of pandemics and build a more resilient world as a key pillar of SDG 3.

The world's response to the COVID-19 pandemic revealed significant shortcomings in global public health emergency preparedness. Particularly in Africa, access to vaccines was unavailable, highlighting the need for better pandemic prediction and prevention. Vaccine hesitancy underscored the importance of engaging all sectors of society. Africa's experience with HIV/AIDS and TB epidemics provided valuable expertise and infrastructure for the COVID-19 response. However, funding shortages and the far-reaching impact of COVID-19 necessitate the establishment of a multi-sectoral entity to strengthen disease control stra

avatar for Vinay K. Nandicoori

Vinay K. Nandicoori

Director, CSIR-CCMB
Dr Vinay Nandicoori is well known Molecular Biologist who has contributed immensely to delineating the signalling networks in Mycobacterium tuberculosis, the causative agent of TB. He did his M.Sc in Biotechnology at Indian Institute of Technology, Bombay and Ph.D in Molecular and... Read More →
avatar for Triona McCormack

Triona McCormack

Director of Research, Director of Research at University College Dublin, Ireland and Member of the Taskforce on Rural Africa and the oversight
Triona is a co-Chair of the Science Summit and leads the team at University College Dublin (UCD) responsible for research strategy, management and operations. She also currently co-chairs the UCD strategic theme on Creating a Sustainable Global Society.Prior to joining UCD, Triona... Read More →
avatar for Kurt Zatloukal

Kurt Zatloukal

Diagnostic and Research Center for Molecular Biomedicine, Director of BBMRI.at, Medical University of Graz
Kurt Zatloukal, M.D. is a professor of pathology at the Medical University of Graz, Austria and is head of the Diagnostic and Research Center for Molecular Biomedicine. His research focuses on the molecular pathology of diseases as well as biobanking and related technologies. He coordinated... Read More →
avatar for declan kirrane

declan kirrane

Chairman, Science Summit UNGA78
Declan Kirrane is the Founder and Managing Director of ISC Intelligence in Science, the chairman and managing director of the science Summit at the United Nations General assembly, and co-founder of Medicines for Future (MAF). He has over 25 years of experience as a global senior... Read More →
avatar for Michael Makanga

Michael Makanga

Executive Director, European Developing Countries Clinical Trials Partnerships - Association
Dr Michael Makanga, MD PhD FRCP: EDCTP Executive Director.Dr Makanga is a clinician-scientist with 28 years of professional experience of working on health and poverty-related infectious diseases in Africa. This includes 24 years of work experience on medical product development and... Read More →
avatar for Magdalena Skipper

Magdalena Skipper

Editor-in-Chief, Nature, Springer/Nature
Dr Magdalena Skipper is Editor in Chief of Nature and Chief Editorial Advisor for the Nature portfolio.A geneticist by training, she holds a PhD from the University of Cambridge, UK. She has considerable editorial and publishing experience, having worked as Chief Editor of Nature... Read More →
avatar for Josef Glössl

Josef Glössl

University Professor, University of Natural Resources and Life Sciences, Vienna (BOKU)
Josef Glössl is Professor emeritus of Applied Genetics and Cell Biology at the University of Natural Resources and Life Sciences, Vienna (BOKU), Austria, where he initiated research on Plant Molecular Pharming (PMP), including glyco-engineering of plants, aiming at optimizing plant... Read More →
avatar for Thomas John

Thomas John

Chief Strategy Officer, Landcent Europe B.V.
After working for several years an information architect and product manager, TJ co-founded Seventh, a go-to-market consultancy to help a burgeoning breed of social entrepreneurs scale at speed, through enabling access to funding and markets. The firm was listed as one of the top... Read More →
avatar for Hervé RAOUL


Assistant Director of ANRS MIE (French National Agency for Research on AIDS - Emerging Infectious Diseases), French National Agency for Research on AIDS - Emerging Infectious Diseases (ANRS MIE)
PhD in biology of blood cells from Paris VII University obtained in 1995 and accreditation to supervise research at the Paris XI University in 2000.From 1989 to 1997, laboratory of Experimental Neurology and Neurovirology at CEA (French Atomic Energy Commission) working on the consequences... Read More →

Mónica Martín-Lanuza Olmeda

Coordinator for International Cooperation and Partnerships, CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS
avatar for Fulufhelo Nelwamondo

Fulufhelo Nelwamondo

CEO, National Research Foundation (NRF)
Prof Fulufhelo Nelwamondo is the CEO of the National Research Foundation of South Africa.He holds a PhD in Electrical Engineering, with specialisation in Computational Intelligence from the University of the Witwatersrand. He was a Postdoctoral Fellow at the Graduate School of Arts... Read More →
avatar for Dr Eugene A. Lottering

Dr Eugene A. Lottering

National Research Foundation, South Africa
avatar for Stefano Bertuzzi

Stefano Bertuzzi

CEO, American Society of Micrombiology
Dr. Stefano Bertuzzi is the Chief Executive Officer of the American Society for Microbiology (ASM). ASM is one of the largest life sciences professional societies in the world, with more than 30,000 members and activities in 122 countries. Its mission is to promote and advance microbial... Read More →
avatar for Carlos Américo Pacheco

Carlos Américo Pacheco

CEO, São Paulo Research Foundation (FAPESP)
Electronic Engineering (ITA - Instituto Tecnológico de Aeronáutica, 1979), Master (1988) and PhD (1996) in Economics (UNICAMP) and Pos-doc in Economics (Columbia University, 2005).Carlos Pacheco is professor of economics at the UNICAMP.Carlos Pacheco was Deputy Minister of Science... Read More →
avatar for Nicola Mulder

Nicola Mulder

Professor, Head of Computational Biology, University of Cape Town, H3ABioNet
I head the Computational Biology Division at the University of Cape Town (UCT) and am a full member of the Institute of Infectious Disease and Molecular Medicine.I lead H3ABioNet, a Pan African Bioinformatics Network of 28 institutions in 17 countries, which is developing bioinformatics... Read More →
avatar for Zisis Kozlakidis

Zisis Kozlakidis

Head of Laboratories Services and Biobanking, IARC/WHO
Dr Zisis Kozlakidis is the Head of Laboratory Services and Biobanking at the International Agency for Research on Cancer, World Health Organization (IARC/WHO). He is responsible for one of the largest and most varied international collections of clinical samples in the world, focusing... Read More →
avatar for Dr. Shevin Jacob

Dr. Shevin Jacob

Chief Scientific Officer, STAIRS; Reader, Liverpool School of Tropical Medicine; Director/co-Founder, Walimu, Walimu
Dr. Shevin Jacob is the chief scientific officer for the sub-Saharan Africa ConsorTium for the Advancement of Innovative Research and Care in Sepsis (STAIRS). He is an infectious disease physician and Reader in Sepsis Research within the Department of Clinical Sciences at the Liverpool... Read More →
avatar for Irene Norstedt

Irene Norstedt

Director, People Directorate, DG Research and Innovation, European Commission
Irene Norstedt works at the European Commission, where she is the Director responsible for the People Directorate within the DG for Research and Innovation.The People Directorate works towards developing a healthy, safe, more equal, free, open and fair society where the voice of the... Read More →
avatar for Seema Kumar

Seema Kumar

CEO, The Cure
Seema Kumar joined Cure Experience in 2022 as the Chief Executive Officer.Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy... Read More →
avatar for Osamu Kunii

Osamu Kunii

CEO, Global Health Innovative Technology Fund(GHIT Fund)
Dr. Osamu Kunii is CEO and Executive Director at the GHIT Fund. He served as a Management Executive Committee member of the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), as Head of the Strategy, Investment and Impact Division. He led one of the largest divisions... Read More →
avatar for Petra Jantzer

Petra Jantzer

Global Life Sciences Lead & Senior Managing Director, Accenture
Petra Jantzer is Senior Managing Director at Accenture and CEO of European Pharmaceuticals and Med Tech Business. In her role, she supports large Life Science companies in bringing innovative medicines to patients and achieving better health outcomes.Petra has more than 20 years of... Read More →

Vinay K. Nandicoori

Director, CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana, India
Vinay K. Nandicoori Director, CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana, India
avatar for Mosoka Fallah

Mosoka Fallah

Africa Center for Disease Control
Dr. Mosoka P. Fallah, most recent position before joining SLL Project of Africa CDC was a short-term Health Security Technical consultant for the World Bank, where he worked on Pandemic diagnostics for Ghana, Liberia and Sierra Leone in the Context of COVID-19. He also served as a... Read More →
avatar for Alison Derbenwick Miller

Alison Derbenwick Miller

Vice President, Oracle for Research
Alison Derbenwick Miller is the Vice President of Oracle for Research, leading Oracle’s global strategy and development for the research industry.  Alison was recognized in Business Insider’s Cloudverse 100 list in 2022 and was named as the 2022 STEM Award Winner by Women Worth... Read More →
avatar for Hillel Lehmann

Hillel Lehmann

Vice President, Head of Transformation & Long-Term Strategy at Nestlé Health Science U.S, Nestlé
Hillel Lehmann serves as Vice President and Head of Corporate Strategy and Transformation at Nestlé Health Science. In his current role he is responsible for defining and executing transformation initiatives across the business, with the objective of accelerating growth and maximizing... Read More →
avatar for Ruxandra Draghia-Akli

Ruxandra Draghia-Akli

Global Head, J&J Global Public Health R&D
Ruxandra Draghia-Akli, MD, Ph.D., leads Johnson & Johnson Global Public Health R&D, advancing discovery, development, and technology capabilities in collaboration with internal and external partners. Ruxandra’s deep knowledge of R&D is matched by an equally deep commitment to improving... Read More →
avatar for Victor Dzau

Victor Dzau

President, United States National Academy of Medicine
avatar for Johan Aubert

Johan Aubert

Chief Digital Officer, Research & Innovation,, L'Oréal
I am a scientist passionated by artificial intelligence and computer vision and I daily contribute to put digital at the service of humans and sciences. As the CDO of L’Oréal Research & Innovation, my role is to lead our teams of Data Scientists, Scientific Computing, Lab Automation... Read More →

Robert R Goodwin

Rob Goodwin, Senior Vice President, Clinical Development and Operations Pfizer Research and Development (PRD), Pfizer

avatar for declan kirrane

declan kirrane

Chairman, Science Summit UNGA78
Declan Kirrane is the Founder and Managing Director of ISC Intelligence in Science, the chairman and managing director of the science Summit at the United Nations General assembly, and co-founder of Medicines for Future (MAF). He has over 25 years of experience as a global senior... Read More →

Thursday September 14, 2023 8:25am - 5:00pm EDT
  Health, One Health